| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 44.270 | 32.200 | 0 | 343 | 0 | 0 | 0 | 0 | 12.130 | - |
| Total Income - EUR | 44.270 | 32.200 | 0 | 343 | 0 | 0 | 0 | 0 | 12.130 | - |
| Total Expenses - EUR | 48.985 | 10.661 | 3.299 | 1.079 | 855 | 886 | -818 | 290 | 289 | - |
| Gross Profit/Loss - EUR | -4.715 | 21.539 | -3.299 | -736 | -855 | -886 | 818 | -290 | 11.841 | - |
| Net Profit/Loss - EUR | -6.043 | 20.775 | -3.299 | -747 | -855 | -886 | 771 | -290 | 10.338 | - |
| Employees | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Amtelemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 11.657 | 18.390 | 17.811 | 18.098 | 17.795 | 17.458 | 17.024 | 16.895 | 60.147 | - |
| Inventories | 183 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 922 | 1.425 | 1.755 | 2.336 | 1.235 | 1.211 | 1.185 | 1.188 | 51.564 | - |
| Cash | 10.551 | 16.965 | 16.057 | 15.762 | 16.561 | 16.247 | 15.839 | 15.706 | 8.583 | - |
| Shareholders Funds | -12.085 | 8.814 | 5.365 | 4.520 | 3.578 | 2.625 | 3.337 | 3.058 | 36.933 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 23.748 | 10.337 | 12.446 | 13.578 | 14.218 | 14.834 | 13.686 | 13.837 | 23.214 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4222 - 4222" | |||||||||
| CAEN Financial Year |
4222
|
|||||||||
Comments - Amtelemed Srl